ICU Medical, Inc. (ICUI) — Fair Value Analysis

Base-case fair value (P50): $174.68 · Current price: $182.98 · Verdict: Fairly Valued

The Verdict on ICUI

Based on comprehensive Monte Carlo simulations, ICU MEDICAL INC (ICUI) is currently assessed as Fairly Valued. Our analysis indicates a median fair value (P50) of $174.68, which positions the current price of $182.98 with an -4.5% against this primary estimate. This marginal difference suggests that ICUI’s market valuation closely aligns with its intrinsic value as derived from thousands of forward-looking scenarios. The company's operational and financial health, categorized as an average quality tier within its sector, underpins this valuation, reflecting a balanced outlook when compared to industry benchmarks and supporting the Fairly Valued verdict.

How ICUI stacks up against peers

ICUI's Fairly Valued status is further informed by its average quality tier assessment. This signifies that, regarding its operational and financial health, ICU Medical performs broadly in line with its sector counterparts, neither significantly outperforming nor underperforming its peer group. The Monte Carlo framework, which generated the $174.68 fair value, integrally incorporates these comparative fundamentals, avoiding undue bias from short-term market fluctuations or speculative trading. Investors should note that while the $182.98 sits very close to $174.68, this average quality tier suggests a lack of significant competitive advantage or disadvantage in its core business relative to other players.

What this means for investors

The analysis concludes that ICUI is Fairly Valued, with its $182.98 presenting an -4.5% compared to our P50 estimate of $174.68. For investors evaluating ICUI, this suggests that the current market price adequately reflects the company's fundamentals given its average quality tier and the results of our probabilistic models. While this primary estimate offers a core perspective, a comprehensive understanding requires examining the full distribution of potential outcomes from our Monte Carlo simulations, including various upside and downside scenarios that expand beyond the $174.68. To access the complete bear and bull case distribution and track ICUI's fair value as new fundamentals are released, sign up for FairCurve today.